JOHN H DUERDEN

CIK 1296981 · President/CEO · last filed 2013-04-29

JOHN H DUERDEN is a President/CEO who has filed 8 SEC Form 4 insider transactions across 2 companies since 2007. Current disclosed insider exposure totals $50.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$50.15M

Companies

2

Total Filings

8

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Obagi Medical Products, Inc. (OMPI) Delisted	Director	15,426	—	—	$0	6	2012-06-08
CROX	President/CEO	368,920	$135.94	$50.15M	$0	1	2010-02-26

Recent Filings

8 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2013-04-29	—	Disp (D)	−15,426	-$370.2K
2012-06-08	Obagi Medical Products, Inc. (OMPI) Delisted	Grant (A)	+2,206	$0	EDGAR
2011-06-09	Obagi Medical Products, Inc. (OMPI) Delisted	Grant (A)	+3,209	$0	EDGAR
2010-06-10	Obagi Medical Products, Inc. (OMPI) Delisted	Grant (A)	+2,463	$0	EDGAR
2010-02-26	CROX	Tax (F)	−31,080	-$236.5K	EDGAR
2009-06-22	Obagi Medical Products, Inc. (OMPI) Delisted	Grant (A)	+4,055	$0	EDGAR
2008-06-12	Obagi Medical Products, Inc. (OMPI) Delisted	Grant (A)	+1,714	$0	EDGAR
2007-12-14	Obagi Medical Products, Inc. (OMPI) Delisted	Grant (A)	+1,779	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.